Right now, state policy regarding medical marijuana use is out ahead of the science, which can lead to predicaments where cannabis is prescribed in situations where it is not needed, explained Kevin P. Hill, MD, MHS, of Beth Israel Deaconess Medical Center and Harvard Medical School.
Right now, state policy regarding medical marijuana use is out ahead of the science, which can lead to predicaments where cannabis is prescribed in situations where it is not needed, explained Kevin P. Hill, MD, MHS, of Beth Israel Deaconess Medical Center and Harvard Medical School.
Transcript
What messages do payers give physicians in response to the rise in legal marijuana?
I think there are areas where it's, unfortunately, predicaments where the policy is ahead of the science. So I talked earlier about a handful of conditions: 3 beyond the 2 FDA-approved conditions. But when you look at the 29 states and the District that have medical cannabis policies, there are over 50 conditions for which various states say cannabis is effective. So I think a lot of times we have people who really are desperate, they want to have effective treatments available, but they're launching ahead using cannabinoids in ways that really haven't been shown to be effective in rigorous clinical trials. And so I think that's unfortunate.
A typical example is, in my field, in substance use disorders, there are people who say that cannabis could be an exit drug, and exit strategy for people using opioids or addicted to opioids. And my initial concern about that is that we actually have 3 FDA-approved medications for opioid use disorders that do actually work fairly well. And so I would be concerned if I knew that a patient who had opioid use disorder was being treated with cannabis as opposed to one of those 3 FDA-approved treatments.
I think there's a right way and a wrong way to do this, and when you have policy out in front of the science, and people launching ahead with these policies, sometimes they're doing it in the wrong way.
Consumers should not eat precut cantaloupe if they do not know the source, as the number of illnesses and recalls tied to a deadly salmonella outbreak grows; the White House and the Department of Education urged schools to take proactive steps to prevent youth drug use; a study published this week found a high prevalence of arrhythmia in patients with long COVID.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
Study Highlights BMP7 as a Potential Therapeutic Target for Ovarian Cancer
November 30th 2023High Bone Morphogenetic Protein 7 (BMP7) expression was significantly associated with aggressive phenotypes, including advanced grade, International Federation of Gynecology and Obstetrics stage, residual disease, and adverse overall survival.
Read More